Piedmont Lithium Inc. (PLL)
| Previous Close | 59.88 |
| Open | 60.20 |
| Bid | 58.00 x 1000 |
| Ask | 60.00 x 800 |
| Day's Range | 57.55 - 60.27 |
| 52 Week Range | 23.56 - 88.97 |
| Volume | 269,955 |
| Avg. Volume | 305,480 |
| Market Cap | 910.951M |
| Beta (5Y Monthly) | 0.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Piedmont Lithium Releases Updated Corporate Presentation for November 2021
NEW YORK, November 10, 2021--Piedmont Lithium Inc., ("Piedmont" or the "Company") (NASDAQ: PLL; ASX: PLL), a leading developer of lithium hydroxide production to enable the North American electric vehicle supply chain, today released a new Corporate Overview Presentation. The updated presentation includes information addressing overall market conditions, lithium supply and demand projections from industry analysts, pricing trends, as well as a status update on Piedmont’s multiple resources in No
- Business Wire
Monique Parker Chosen to Lead Piedmont Lithium Health, Safety, and Environment
NEW YORK, October 28, 2021--Piedmont Lithium Inc., ("Piedmont" or the "Company") (NASDAQ: PLL; ASX: PLL), a leading developer of lithium hydroxide production to enable the North American electric vehicle supply chain, today announced that Monique Parker has joined the Company as Vice President of Health, Safety, and Environment. Reporting to Chief Operating Officer, David Klanecky, Ms. Parker brings more than a decade of experience managing environmental, health and safety operations for some of
- GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Provention Bio, Danimer Scientific, AcelRX, and Piedmont Lithium on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Provention Bio, Inc. (NASDAQ: PRVB), Danimer Scientific, Inc. (NYSE: DNMR), AcelRX Pharmaceuticals, Inc. (NASDAQ: ACRX), and Piedmont Lithium Inc. (NASDAQ: PLL) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Provention Bio, Inc. (NASDAQ: PRVB) Bragar Eage
